What is SDEV's earnings growth forecast for 2026-2026?
(NYSEMKT: SDEV) Stablecoin Development's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Stablecoin Development's earnings in 2026 is -$22,141,000.
In 2026, SDEV is forecast to generate -$10,218,686 in earnings, with the lowest earnings forecast at -$9,915,161 and the highest earnings forecast at -$10,623,387.
What is SDEV's revenue growth forecast for 2026-2026?
(NYSEMKT: SDEV) Stablecoin Development's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Stablecoin Development's revenue in 2026 is $0.
In 2026, SDEV is forecast to generate $426,106,964 in revenue, with the lowest revenue forecast at $413,460,075 and the highest revenue forecast at $442,987,233.
What is SDEV's forecast return on assets (ROA) for 2026-2026?
(NYSEMKT: SDEV) forecast ROA is -113.1%, which is lower than the forecast US Biotechnology industry average of -16.31%.
What is SDEV's Earnings Per Share (EPS) forecast for 2026-2026?
(NYSEMKT: SDEV) Stablecoin Development's current Earnings Per Share (EPS) is -$3.80. In 2026, SDEV's EPS is forecast to hit -$0.38 (min: -$0.37, max: -$0.40).
What is SDEV's forecast return on equity (ROE) for 2026-2026?
(NYSEMKT: SDEV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.